Members' News

14 Dec 2020

Intuitive Investments Group admitted onto AIM

David Evans' Intuitive Investments Group (IIG) has today been Admitted onto London’s AIM.

1 Dec 2020

ILC Therapeutics announces first international investment

UK biotech company ILC Therapeutics announces first international investment

19 Nov 2020

KKR to acquire animal health firm Argenta for about $100 million

KKR & Co Inc will buy a majority stake in animal health firm Argenta Limited, as the pet and animal care industry continues to draw private sector interest.

16 Nov 2020

Intelligent Tissue Group launches Clinical Trials Facility to Boost Global Operations

21 Oct 2020

Regulating Medical Devices from 1 January 2021

New Guidance, should the UK fail to achive a trade deal with the EU, has now been made available here.

16 Oct 2020

NovaBiotics Innovate UK COVID-19 grant award for Nylexa

NovaBiotics receives £1m Innovate UK grant to fund its COVID-19 Nylexa therapy programme.

13 Oct 2020

Nucana raises $80Million in follow on funding

NuCana Expands its Board of Directors with the Appointment of Bali Muralidhar

12 Oct 2020

ILC Therapeutics COVID-19 Drug Breakthrough

ILC Therapeutics Announces ‘Significant’ COVID-19 Drug Breakthrough

18 Sep 2020

Safety-critical alerts are changing at the MHRA

Changes are being made to the way the Medicines and Healthcare products Regulatory Agency (MHRA) issues safety-critical alerts to healthcare providers.

1 Sep 2020

TUV SUD Measurement for Recovery Programme

TÜV SÜD National Engineering Laboratory (NEL), in collaboration with its partner UK measurement laboratories, is helping companies recover from COVID-19. The Measurement for Recovery (M4R) Programme, which is now open …

1 Sep 2020

Biotechnology sector expert bolsters Entrust growth

Executive search consultancy, Entrust, has announced the appointment of Mark Johnson as Senior Partner of its Oxford-based Global Healthcare arm.

1 Sep 2020

MHRA Update on MDR and IVDR

 The MHRA has confirmed that, in a departure from the EU Withdrawal Agreement, the UK will now not be implementing the MDR and IVDR post the transition period. For further details please see here.

17 Aug 2020

MIJ Launches a New Biotech Fund in Partnership with Nippon Shinyaku and Torii Pharmaceutical

Bamburgh Capital Limited is pleased to announce that MIJ has secured commitments from two prestigious Japanese Pharmaceutical companies totalling 20 billion Yen, approximately 20 million dollars. Over the next twelve mo…

17 Aug 2020

Cellexus begin growth drive

Dundee biotech, Cellexus, started on a growth drive this quarter with the addition of two new team members.

26 Jun 2020

RoslinCT announces the construction of a new Cell & Gene therapy manufacturing facility.

RoslinCT announces the construction of a new Cell & Gene therapy manufacturing facility.